Mass-spectrometric exploration of proteome structure and function
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Numerous biological processes are concurrently and coordinately active in every living cell. Each of them encompasses synthetic, catalytic and regulatory functions that are, almost always, carried out by proteins organized further into higher-order structures and networks. For decades, the structures and functions of selected proteins have been studied using biochemical and biophysical methods. However, the properties and behaviour of the proteome as an integrated system have largely remained elusive. Powerful mass-spectrometry-based technologies now provide unprecedented insights into the composition, structure, function and control of the proteome, shedding light on complex biological processes and phenotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Contemporary proteomic research relies heavily on high-resolution mass spectrometry (HR-MS) platforms including Orbitrap and time-of-flight (TOF) systems.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [168]
In the citing paper
“These tools quantify thousands of proteins across a wide dynamic range168,169.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [168]
In the citing paper
“In contrast to shotgun “bottom-up” proteomics (26, 27), which employs proteolytic digestion of proteins prior to MS analysis introducing a “peptide-to-protein” inference problem”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [27]
In the citing paper
“However, antibody-based approaches heavily rely on prior knowledge of protein targets. While MS-based techniques provide information without a priori knowledge, shotgun bottom-up proteomics has intrinsic limitations due to the “peptide-to-protein” inference problem and is, therefore, unable to provide proteoform-specific information (12, 27).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [27]
In the citing paper
“Unlike genomics, proteomics more precisely reflects cellular responses and disease phenotypes (21, 27, 28).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [27]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
Self-citationThe Perseus computational platform for comprehensive analysis of (prote)omics data
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., & Cox, J. (2016) · Nature Methods · doi:10.1038/nmeth.3901 · Cited by 8,803
Self-citationMass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Self-citationGlobal quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Cox, J., Hein, M. Y., Luber, C. A., Paron, I., Nagaraj, N., & Mann, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031591 · Cited by 5,180
Self-citationSkyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697
From molecular to modular cell biology.
Hartwell, L. H., Hopfield, J. J., Leibler, S., & Murray, A. W. (1999) · Nature · doi:10.1038/35011540 · Cited by 3,632
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.09.026 · Cited by 3,499
Self-citationGillet, L. C., Navarro, P., Tate, S., Röst, H., Selevsek, N., Reiter, L., Bonner, R., & Aebersold, R. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.016717 · Cited by 2,877
Self-citation
Cited by
Items 101–200 of 1,007
Dynamic 3D proteomes reveal protein functional alterations at high resolution in situ
Cappelletti, V., Hauser, T., Piazza, I., Pepelnjak, M., Malinovska, L., Fuhrer, T., Li, Y., Dörig, C., Boersema, P., Gillet, L., et al. (2021) · Cell · doi:10.1016/j.cell.2020.12.021 · Cited by 176
“LiP-MS and other structural proteomics approaches have been used in numerous protein structural studies (Aebersold and Mann, 2016; Huber et al., 2015; Leuenberger et al., 2017; Liu et al., 2018; Piazza et al., 2018; Savitski et al., 2014).”
Analytical and Biochemical Perspectives of Protein O-GlcNAcylation
Ma, J., Wu, C., & Hart, G. W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00884 · Cited by 169
Recent advances in proteomics and metabolomics in plants
Yan, S., Bhawal, R. P., Yin, Z., Thannhauser, T. W., & Zhang, S. (2022) · Molecular Horticulture · doi:10.1186/s43897-022-00038-9 · Cited by 188
“…advances in determining composition, regulation and function of molecular complexes have been obtained by MS-based proteomics (called interaction proteomics or interactomics) leading to a greater understanding of the molecular basis of complex biological processes (Aebersold and Mann 2016).”
BackgroundKitata, R. B., Yang, J., & Chen, Y. (2023) · Mass Spectrometry Reviews · doi:10.1002/mas.21781 · Cited by 165
Coscia, F., Lengyel, E., Duraiswamy, J., Ashcroft, B., Bassani-Sternberg, M., Wierer, M., Johnson, A., Wroblewski, K., Montag, A., Yamada, S. D., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.065 · Cited by 167
Self-citationSingle-cell protein analysis by mass spectrometry
Slavov, N. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.04.018 · Cited by 164
“Mass spectrometry (MS) allows quantitative protein analysis at large scale [1, 2].”
BackgroundMuntel, J., Gandhi, T., Verbeke, L., Bernhardt, O. M., Treiber, T., Bruderer, R., & Reiter, L. (2019) · Molecular Omics · doi:10.1039/c9mo00082h · Cited by 163
Acquisition and Analysis of DIA-Based Proteomic Data: A Comprehensive Survey in 2023
Lou, R., & Shui, W. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100712 · Cited by 177
“Ronghui Lou 1,2,* and Wenqing Shui 1,2,* Data-independent acquisition(DIA)mass spectrometry (MS) has emerged as a powerful technology for high-throughput, accurate, and reproducible quantitative proteomics.”
BackgroundMateus, A., Määttä, T. A., & Savitski, M. M. (2016) · Proteome Science · doi:10.1186/s12953-017-0122-4 · Cited by 156
“To allow proteome-wide studies of drug-protein interactions in a single experiment, the CETSA principles were combined with mass spectrometry-based proteomics [9, 32] in the thermal proteome profiling (TPP) approach [15–18].”
BackgroundMethodUnderstanding extracellular vesicle diversity – current status
Greening, D. W., & Simpson, R. J. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1537788 · Cited by 160
“Increasingly, proteomics is using technologies to not only investigate protein level changes, but also the complex interactions of signaling molecules and networks [332].”
BackgroundSpatially and cell-type resolved quantitative proteomic atlas of healthy human skin
Dyring-Andersen, B., Løvendorf, M. B., Coscia, F., Santos, A., Møller, L. B. P., Colaço, A. R., Niu, L., Bzorek, M., Doll, S., Andersen, J. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19383-8 · Cited by 156
Self-citationWang, S., Li, W., Hu, L., Cheng, J., Yang, H., & Liu, Y. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa498 · Cited by 163
“Three case-study datasets acquired by DIA-MS (or SWATH-MS) (12,22) were included for testing the availability and capability of NAguideR .”
InfluentialChemical profiling of DNA G-quadruplex-interacting proteins in live cells
Zhang, X., Spiegel, J., Martínez Cuesta, S., Adhikari, S., & Balasubramanian, S. (2021) · Nature Chemistry · doi:10.1038/s41557-021-00736-9 · Cited by 159
Roberts, D. S., Loo, J. A., Tsybin, Y. O., Liu, X., Wu, S., Chamot-Rooke, J., Agar, J. N., Paša-Tolić, L., Smith, L. M., & Ge, Y. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00318-2 · Cited by 161
Next-generation computational tools for interrogating cancer immunity
Finotello, F., Rieder, D., Hackl, H., & Trajanoski, Z. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0166-7 · Cited by 162
Muntel, J., Kirkpatrick, J., Bruderer, R., Huang, T., Vitek, O., Ori, A., & Reiter, L. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00898 · Cited by 163
Methods, Tools and Current Perspectives in Proteogenomics
Ruggles, K. V., Krug, K., Wang, X., Clauser, K. R., Wang, J., Payne, S. H., Fenyö, D., Zhang, B., & Mani, D. R. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.mr117.000024 · Cited by 148
“supplied protein sequence database (25).”
Lapek, J. D., Greninger, P., Morris, R., Amzallag, A., Pruteanu-Malinici, I., Benes, C. H., & Haas, W. (2017) · Nature Biotechnology · doi:10.1038/nbt.3955 · Cited by 158
High-throughput proteomics and AI for cancer biomarker discovery
Xiao, Q., Zhang, F., Xu, L., Yue, L., Kon, O. L., Zhu, Y., & Guo, T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113844 · Cited by 161
From coarse to fine: the absolute Escherichia coli proteome under diverse growth conditions
Mori, M., Zhang, Z., Banaei‐Esfahani, A., Lalanne, J., Okano, H., Collins, B. C., Schmidt, A., Schubert, O. T., Lee, D., Li, G., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209536 · Cited by 149
“Over the last decades, liquid-chromatography coupled to tandem mass spectrometry (LC-MS/MS) has matured to be the method of choice for generating quantitative proteomic data (Aebersold & Mann, 2003, 2016).”
Self-citationLangenegger, N., Nentwig, W., & Kuhn‐Nentwig, L. (2019) · Toxins · doi:10.3390/toxins11100611 · Cited by 156
“In the last years the focus of venomic studies experienced a shift from single protein analysis to comprehensive assessment of the whole transcriptome and proteome, which is today possible with extreme sensitivity [263,284].”
BackgroundZhu, Y., Dou, M., Piehowski, P. D., Liang, Y., Wang, F., Chu, R. K., Chrisler, W. B., Smith, J. N., Schwarz, K. C., Shen, Y., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.000686 · Cited by 147
Mass spectrometry–based protein identification in proteomics—a review
Noor, Z., Ahn, S. B., Baker, M. S., Ranganathan, S., & Mohamedali, A. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz163 · Cited by 148
Zhou, M., Lantz, C., Brown, K. A., Ge, Y., Paša-Tolić, L., Loo, J. A., & Lermyte, F. (2020) · Chemical Science · doi:10.1039/d0sc04392c · Cited by 146
Multi-omic Profiling Reveals Dynamics of the Phased Progression of Pluripotency
Yang, P., Humphrey, S. J., Cinghu, S., Pathania, R., Oldfield, A. J., Kumar, D., Perera, D., Yang, J. Y. H., James, D. E., Mann, M., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.03.012 · Cited by 146
Self-citationHernández‐Mesa, M., Escourrou, A., Monteau, F., Bizec, B. L., & Dervilly, G. (2017) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2017.07.006 · Cited by 145
A multiregional proteomic survey of the postnatal human brain
Carlyle, B. C., Kitchen, R. R., Kanyo, J. E., Voss, E. Z., Pletikos, M., Sousa, A. M. M., Lam, T. T., Gerstein, M. B., Sestan, N., & Nairn, A. C. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0011-2 · Cited by 143
Chemical cross-linking with mass spectrometry: a tool for systems structural biology
Chavez, J. D., & Bruce, J. E. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.08.006 · Cited by 141
Personalized Drug Therapy: Innovative Concept Guided With Proteoformics
Su, J., Yang, L., Sun, Z., & Zhan, X. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100737 · Cited by 163
“Targeted proteomics is a method that identi fi es key protein targets associated with tumorigenesis and development, which is performed by analyzing protein expression levels and functions in tumor cells or tissues (77, 78).”
MethodComputational Methods for Understanding Mass Spectrometry–Based Shotgun Proteomics Data
Sinitcyn, P., Rudolph, J. D., & Cox, J. (2018) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-080917-013516 · Cited by 143
Recent Advances in Glycoproteomic Analysis by Mass Spectrometry
Suttapitugsakul, S., Sun, F., & Wu, R. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04651 · Cited by 142
Li, J., Zhang, M., Sun, J., Mao, X., Wang, J., Liu, H., Zheng, H., Li, X., Zhao, H., & Zou, D. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00477 · Cited by 139
“Protein structure determines its function (Aebersold and Mann, 2016).”
Messner, C. B., Demichev, V., Wang, Z., Hartl, J., Kustatscher, G., Mülleder, M., & Ralser, M. (2022) · PROTEOMICS · doi:10.1002/pmic.202200013 · Cited by 154
Irmisch, A., Bonilla, X., Chevrier, S., Lehmann, K.-V., Singer, F., Toussaint, N. C., Esposito, C., Mena, J., Milani, E. S., Casanova, R., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.004 · Cited by 149
The proteomic landscape of synaptic diversity across brain regions and cell types
van Oostrum, M., Blok, T. M., Giandomenico, S. L., tom Dieck, S., Tushev, G., Fürst, N., Langer, J. D., & Schuman, E. M. (2023) · Cell · doi:10.1016/j.cell.2023.09.028 · Cited by 135
Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease
Dey, K. K., Wang, H., Niu, M., Bai, B., Wang, X., Li, Y., Cho, J.-H., Tan, H., Mishra, A., High, A. A., et al. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9237-1 · Cited by 135
“Advances in mass spectrometry (MS)-based proteomics [8, 9], especially in LC separation power and MS resolution and scan rate, enable the profiling of more than 15,000 proteins (> 12,000 genes) from mammalian tissue samples [10, 11].”
BackgroundSex estimation using sexually dimorphic amelogenin protein fragments in human enamel
Parker, G. J., Yip, J. M., Eerkens, J. W., Salemi, M., Durbin-Johnson, B., Kiesow, C., Haas, R., Buikstra, J. E., Klaus, H., Regan, L. A., et al. (2019) · Journal of Archaeological Science · doi:10.1016/j.jas.2018.08.011 · Cited by 138
“The peptides are converted from being in solution to gas phase using electrospray ionization, which gently removes the surrounding liquid and adds a positive charge (Aebersold and Mann, 2016).”
BackgroundInfluentialHigh‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
Geyer, P. E., Arend, F. M., Doll, S., Louiset, M.-L., Winter, S. V., Müller, J., Torun, F. M., Weigand, M., Eichhorn, P., Bruegel, M., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114167 · Cited by 157
“Mass spectrometry (MS)-based proteomics is the method of choice to globally investigate proteins in a biological system—its proteome (Aebersold & Mann, 2016).”
Self-citationProtein identification by nanopore peptide profiling
Lucas, F. L. R., Versloot, R. C. A., Yakovlieva, L., Walvoort, M. T. C., & Maglia, G. (2021) · Nature Communications · doi:10.1038/s41467-021-26046-9 · Cited by 145
Tumor organoid models in precision medicine and investigating cancer-stromal interactions
Xu, R., Zhou, X., Wang, S., & Trinkle, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107668 · Cited by 134
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs
Gerdes, H., Casado, P., Dokal, A., Hijazi, M., Akhtar, N., Osuntola, R., Rajeeve, V., Fitzgibbon, J., Travers, J., Britton, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22170-8 · Cited by 132
Strategies to enable large-scale proteomics for reproducible research
Poulos, R. C., Hains, P. G., Shah, R., Lucas, N., Xavier, D., Manda, S. S., Anees, A., Koh, J. M. S., Mahboob, S., Wittman, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17641-3 · Cited by 140
Self-citationA Perspective on Extracellular Vesicles Proteomics
Rosa-Fernandes, L., Bombarda-Rocha, V., Carregari, V. C., Urbani, A., & Palmisano, G. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00102 · Cited by 143
“Bottom-up proteomics approaches have allowed the identification and quantification of the complete proteome of biological systems (Yates et al., 2009; Aebersold and Mann, 2016).”
BackgroundMass spectrometry using electrospray ionization
Prabhu, G. R. D., Williams, E. R., Wilm, M. S., & Urban, P. L. (2023) · Nature Reviews Methods Primers · doi:10.1038/s43586-023-00203-4 · Cited by 148
Quality control in mass spectrometry‐based proteomics
Bittremieux, W., Tabb, D. L., Impens, F., Staes, A., Timmerman, E., Martens, L., & Laukens, K. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21544 · Cited by 124
Application of targeted mass spectrometry in bottom-up proteomics for systems biology research
Manes, N. P., & Nita‐Lazar, A. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.02.008 · Cited by 137
“Bottom-up proteomics using high-performance liquid chromatography coupled to mass spectrometry (LC-MS) has developed into a powerful and highly versatile technology that is enabling rapid advances in diverse areas of biomedical research, clinical diagnostics, and biotechnology [1, 2].”
BackgroundSpatial proteomics in three-dimensional intact specimens
Bhatia, H. S., Brunner, A.-D., Öztürk, F., Kapoor, S., Rong, Z., Mai, H., Thielert, M., Ali, M., Al-Maskari, R., Paetzold, J. C., et al. (2022) · Cell · doi:10.1016/j.cell.2022.11.021 · Cited by 129
Self-citationKugeratski, F. G., Atkinson, S. J., Neilson, L. J., Lilla, S., Knight, J. R. P., Serneels, J., Juin, A., Ismail, S., Bryant, D. M., Markert, E. K., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aan8247 · Cited by 125
“…technology and robust platforms for data analysis allow in-depth and highly accurate quantitative analysis of cellular and sub-cellular proteomes (19–21), E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s including those…”
Dai, L., Prabhu, N., Yu, L. Y., Bacanu, S., Ramos, A. D., & Nordlund, P. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012837 · Cited by 130
High throughput discovery of functional protein modifications by Hotspot Thermal Profiling
Huang, J. X., Lee, G., Cavanaugh, K. E., Chang, J. W., Gardel, M. L., & Moellering, R. E. (2019) · Nature Methods · doi:10.1038/s41592-019-0499-3 · Cited by 133
An Introduction to Advanced Targeted Acquisition Methods
van Bentum, M., & Selbach, M. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100165 · Cited by 132
“tions/quantifications per measurement time (1, 2).”
The structural context of posttranslational modifications at a proteome-wide scale
Bludau, I., Willems, S., Zeng, W.-F., Strauss, M. T., Hansen, F. M., Tanzer, M. C., Karayel, O., Schulman, B. A., & Mann, M. (2022) · PLOS Biology · doi:10.1371/journal.pbio.3001636 · Cited by 123
“Mass spectrometry (MS)-based proteomics has become the method of choice not only to identify and quantify proteomes [1,2], but also to investigate PTMs on a proteome-wide scale [3–5].”
BackgroundSelf-citationWegler, C., Gaugaz, F. Z., Andersson, T. B., Wiśniewski, J. R., Busch, D., Gröer, C., Oswald, S., Norén, A., Weiss, F., Hammer, H. S., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00364 · Cited by 121
Inference and quantification of peptidoforms in large sample cohorts by SWATH-MS
Rosenberger, G., Liu, Y., Röst, H. L., Ludwig, C., Buil, A., Bensimon, A., Soste, M., Spector, T. D., Dermitzakis, E. T., Collins, B. C., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3908 · Cited by 127
Self-citationTrabjerg, E., Nazari, Z. E., & Rand, K. D. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.06.008 · Cited by 125
Sequence-to-sequence translation from mass spectra to peptides with a transformer model
Yilmaz, M., Fondrie, W. E., Bittremieux, W., Melendez, C. F., Nelson, R., Ananth, V., Oh, S., & Noble, W. S. (2024) · Nature Communications · doi:10.1038/s41467-024-49731-x · Cited by 114
“While this is often the case for samples generated from species with well-characterized genomes, relying on a database prevents the detection of unexpected peptides.”
Ferguson, I. D., Patiño-Escobar, B., Tuomivaara, S. T., Lin, Y.-H. T., Nix, M. A., Leung, K. K., Kasap, C., Ramos, E., Nieves Vasquez, W., Talbot, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31810-6 · Cited by 118
Ctortecka, C., Clark, N. M., Boyle, B. W., Seth, A., Mani, D. R., Udeshi, N. D., & Carr, S. A. (2024) · Nature Communications · doi:10.1038/s41467-024-49651-w · Cited by 115
“Those dedicated diaPASEFstrategies allow one to focus on the most productive precursor population (i.e., 400 − 1000m/z), while excluding most singly charged contaminating ions.”
The RTK Interactome: Overview and Perspective on RTK Heterointeractions
Paul, M. D., & Hristova, K. A. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00467 · Cited by 128
Phosphorylation of the Ribosomal Protein RPL12/uL11 Affects Translation during Mitosis
Imami, K., Milek, M., Bogdanow, B., Yasuda, T., Kastelic, N., Zauber, H., Ishihama, Y., Landthaler, M., & Selbach, M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.08.019 · Cited by 107
The social and structural architecture of the yeast protein interactome
Michaelis, A. C., Brunner, A.-D., Zwiebel, M., Meier, F., Strauss, M. T., Bludau, I., & Mann, M. (2023) · Nature · doi:10.1038/s41586-023-06739-5 · Cited by 119
“Given the importance of the interactome for functional understanding and the substantial improvements in mass spectrometry technology during the past decade 7,8 , we set out to generate a substantially complete interactome of all proteins present in an organism in a given state.”
BackgroundSelf-citationHosp, F., Gutiérrez-Ángel, S., Schaefer, M. H., Cox, J., Meissner, F., Hipp, M. S., Hartl, F.-U., Klein, R., Dudanova, I., & Mann, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.097 · Cited by 123
“Mass spectrometry (MS)-based quantitative proteomics is powerful technology for systems-wide analysis of complex cellular processes (Aebersold and Mann, 2016).”
BackgroundSelf-citationMaxQuant.Live Enables Global Targeting of More Than 25,000 Peptides
Wichmann, C., Meier, F., Virreira Winter, S., Brunner, A.-D., Cox, J., & Mann, M. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.001131 · Cited by 118
Self-citationNiu, M., Cho, J.-H., Kodali, K., Pagala, V., High, A. A., Wang, H., Wu, Z., Li, Y., Bi, W., Zhang, H., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04415 · Cited by 118
Schiller, H. B., Mayr, C. H., Leuschner, G., Strunz, M., Staab-Weijnitz, C., Preisendörfer, S., Eckes, B., Moinzadeh, P., Krieg, T., Schwartz, D. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2263oc · Cited by 116
“12 Discussion Mass spectrometry driven proteomics evolved into a highly sensitive and accurate technology that enables the precise quantification of thousands of proteins at once [37].”
BackgroundSelf-citationIn vivo brain GPCR signaling elucidated by phosphoproteomics
Liu, J. J., Sharma, K., Zangrandi, L., Chen, C., Humphrey, S. J., Chiu, Y.-T., Spetea, M., Liu-Chen, L.-Y., Schwarzer, C., & Mann, M. (2018) · Science · doi:10.1126/science.aao4927 · Cited by 118
Self-citationThe Case for Proteomics and Phospho‐Proteomics in Personalized Cancer Medicine
Doll, S., Gnad, F., & Mann, M. (2019) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201800113 · Cited by 117
Self-citationLi, X., Zhong, C., Wu, R., Xu, X., Yang, Z., Cai, S., Wu, X., Chen, X., Yin, Z., He, Q., et al. (2021) · Protein & Cell · doi:10.1007/s13238-020-00810-x · Cited by 125
Asleh, K., Dery, V., Taylor, C., Davey, M., Djeungoue‐Petga, M., & Ouellette, R. J. (2023) · Biomarker Research · doi:10.1186/s40364-023-00540-2 · Cited by 133
“Targeted proteomics approaches are other emerging techniques that can be used for EV protein biomarker validation in which MS data acquisition is directed towards selecting and fragmenting specific peptides and monitoring their ions including low-abundant protein targets [144, 147].”
Method27-Plex Tandem Mass Tag Mass Spectrometry for Profiling Brain Proteome in Alzheimer’s Disease
Wang, Z., Yu, K., Tan, H., Wu, Z., Cho, J.-H., Han, X., Sun, H., Beach, T. G., & Peng, J. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00655 · Cited by 118
Vps34 Kinase Domain Dynamics Regulate the Autophagic PI 3-Kinase Complex
Stjepanovic, G., Baskaran, S., Lin, M. G., & Hurley, J. H. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.003 · Cited by 110
“To study protein interactions in PI3K in solution by a complementary approach, we subjected the intact complex to CX-MS (Aebersold and Mann, 2016; Chait et al., 2016; Liu and Heck, 2015).”
MethodInfluentialItzhak, D. N., Davies, C., Tyanova, S., Mishra, A., Williamson, J., Antrobus, R., Cox, J., Weekes, M. P., & Borner, G. H. H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.063 · Cited by 124
“…al., 2016; Foster et al., 2006; Hesketh et al., 2017; Itzhak et al., 2016; Jadot et al., 2017; Jean Beltran et al., 2016; Mardakheh et al., 2016; Rhee et al., 2013; Weekes et al., 2014; reviewed in Aebersold and Mann, 2016; Drissi et al., 2013; Jean Beltran et al., 2017; Larance and Lamond, 2015).”
BackgroundSensitive Determination of Proteolytic Proteoforms in Limited Microscale Proteome Samples
Weng, S. S. H., Demir, F. O., Ergin, E. K., Dirnberger, S., Uzozie, A. C., Tuscher, D., Nierves, L. A., Tsui, J., Huesgen, P. F., & Lange, P. F. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001560 · Cited by 120
“Current peptide-based bottom-up proteomics enables protein identification and quantification on a proteome-wide scale (6), but standard protocols and database search parameters exclude N termini identification, particularly of the protease-generated neo-N-terminal peptides (7).”
Le, J., Dian, Y., Zhao, D., Guo, Z., Luo, Z., Chen, X., Zeng, F., & Deng, G. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02426-3 · Cited by 130
Recent trends of capillary electrophoresis‐mass spectrometry in proteomics research
Gomes, F. P., & Yates, J. R. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21599 · Cited by 112
Kulenkampff, K., Perez, A.-M. W., Sormanni, P., Habchi, J., & Vendruscolo, M. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00254-9 · Cited by 116
A systems approach to infectious disease
Eckhardt, M., Hultquist, J. F., Kaake, R. M., Hüttenhain, R., & Krogan, N. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0212-5 · Cited by 112
Advances in bulk and single-cell multi-omics approaches for systems biology and precision medicine
Li, Y., Ma, L., Wu, D., & Chen, G. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab024 · Cited by 133
Analytical techniques for multiplex analysis of protein biomarkers
van Gool, A. J., Corrales, F. J., Čolović, M. B., Krstic, D. Z., Oliver‐Martos, B., Martínez-Cáceres, E. M., Jakaša, I., Gajski, G., Brun, V., Kyriacou, K. C., et al. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1763174 · Cited by 119
“modifications and specific metabolic isoforms of specific biochemical interactions [48,49].”
BackgroundHidden proteome of synaptic vesicles in the mammalian brain
Taoufiq, Z., Ninov, M., Villar-Briones, A., Wang, H.-Y., Sasaki, T., Roy, M. C., Beauchain, F., Mori, Y., Yoshida, T., Takamori, S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011870117 · Cited by 104
“Additionally, the probability of obtaining peptides with similar masses, but different amino acid sequences, increases with increasing sample complexity (11, 12).”
BackgroundPrediction of peptide mass spectral libraries with machine learning
Cox, J. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01424-w · Cited by 115
Tandem mass spectrum prediction for small molecules using graph transformers
Young, A., Röst, H. L., & Wang, B. (2024) · Nature Machine Intelligence · doi:10.1038/s42256-024-00816-8 · Cited by 150
“Because of its versatility, LC–MS/MS is commonly employed in a variety of domains, including proteomics 3 , metabolomics 4,5 , forensics 6,7 and environmental chemistry 8 .”
Ion Activation Methods for Peptides and Proteins
Macias, L. A., Santos, I. C., & Brodbelt, J. S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04859 · Cited by 107
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
“While MS-based techniques provide information without a priori knowledge, shotgun bottom-up proteomics has intrinsic limitations due to the “peptide-to-protein” inference problem and is, therefore, unable to provide proteoform-specific information (12, 27).”
BackgroundComes, A. L., Papiol, S., Müeller, T., Geyer, P. E., Mann, M., & Schulze, T. G. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0219-2 · Cited by 121
Self-citationGoeminne, L. J. E., Gevaert, K., & Clement, L. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.04.004 · Cited by 113
Belliveau, N. M., Barnes, S. L., Ireland, W. T., Jones, D. L., Sweredoski, M. J., Moradian, A., Hess, S., Kinney, J. B., & Phillips, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722055115 · Cited by 110
Li, F., Zhou, Y., Zhang, Y., Yin, J., Qiu, Y., Gao, J., & Zhu, F. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac040 · Cited by 113
Moyamoya disease emerging as an immune-related angiopathy
Asselman, C., Hemelsoet, D., Eggermont, D., Dermaut, B., & Impens, F. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.08.009 · Cited by 105
Arslan, M., Tahir, H. E., Zareef, M., Shi, J., Rakha, A., Bilal, M., Huang, X., Li, Z., & Xiaobo, Z. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.11.021 · Cited by 106
Hartman, E., Scott, A. M., Karlsson, C. A. Q., Mohanty, T., Vaara, S. T., Linder, A., Malmström, L., & Malmström, J. A. (2023) · Nature Communications · doi:10.1038/s41467-023-41146-4 · Cited by 120
Dowling, P., Gargan, S., Swandulla, D., & Ohlendieck, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032415 · Cited by 109
“Proteomics is a key technology of modern biosciences [44] and crucial for advances in pharmacological research and biotechnology [45], as well as biomarker discovery [46].”
BackgroundA comparison of proteomic, genomic, and osteological methods of archaeological sex estimation
Buonasera, T. Y., Eerkens, J. W., de Flamingh, A., Engbring, L., Yip, J. M., Li, H., Haas, R., DiGiuseppe, D., Grant, D., Salemi, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68550-w · Cited by 111
Deep learning neural network tools for proteomics
Meyer, J. G. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100003 · Cited by 116
“Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is currently the most effective method to discover and quantify the human proteome (Aebersold and Mann, 2016), enabling a proteomic depth now comparable with RNA sequencing (Bekker-Jensen et al.”
MethodRecent advances (2019–2021) of capillary electrophoresis‐mass spectrometry for multilevel proteomics
Chen, D., McCool, E. N., Yang, Z., Shen, X., Lubeckyj, R. A., Xu, T., Wang, Q., & Sun, L. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21714 · Cited by 106
A Practical Guide to Small Protein Discovery and Characterization Using Mass Spectrometry
Ahrens, C. H., Wade, J. T., Champion, M. M., & Langer, J. D. (2021) · Journal of Bacteriology · doi:10.1128/jb.00353-21 · Cited by 108
Exploring the extracellular matrix in health and disease using proteomics
Taha, I. N., & Naba, A. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190001 · Cited by 101
Richardson, K., Langridge, D., Dixit, S. M., & Ruotolo, B. T. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04948 · Cited by 110
Liu, J. J., Chiu, Y.-T., DiMattio, K. M., Chen, C., Huang, P., Gentile, T. A., Muschamp, J. W., Cowan, A., Mann, M., & Liu‐Chen, L. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0155-0 · Cited by 106
Self-citationPhosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer
Francavilla, C., Lupia, M., Tsafou, K., Villa, A., Kowalczyk, K. M., Jersie-Christensen, R., Bertalot, G., Confalonieri, S., Brunak, S., Jensen, L. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.015 · Cited by 102
“Mass spectrometry (MS)based proteomics has undergone enormous improvements in the past few years because of more accurate instrumentation and better methods for sample preparation and quantitation (Aebersold and Mann, 2016).”
Background
Metadata
- Authors
- Aebersold, R., & Mann, M.
- Affiliations
- University of Zurich (CH)
- University of Copenhagen (DK)
- Corresponding author
- Aebersold, Ruedi
- Mann, Matthias
- Venue
- Nature
- Published
- 2016-09
- Volume
- 537
- Issue
- 7620
- Pages
- 347-355
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2519691041
- Cited by
- 2,334
- References
- 121
- Citations by year
- 2026: 322 · 2025: 298 · 2024: 229 · 2023: 217 · 2022: 203 · 2021: 248 · 2020: 232 · 2019: 211 · 2018: 200 · 2017: 156 · 2016: 12
- FWCI
- 19.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- proteome, protein networks, protein higher-order structure, mass spectrometry-based proteomics, protein regulation
- MeSH terms
- Animals, Humans, Phenotype, Protein Processing, Post-Translational, Mass Spectrometry, Signal Transduction, Proteome, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.